Anzeige
Mehr »
Login
Sonntag, 22.12.2024 Börsentäglich über 12.000 News von 679 internationalen Medien
Breaking News: Vorweihnachtlicher Kaufrausch an der Börse?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Technology

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
11.12.Overcoming the first hurdles: Navigating early phase challenges for biotechs
11.12.Relation-GSK to drive fibrotic and osteoarthritis developments
11.12.Better prevention and treatment options needed for genital herpes, WHO says
11.12.Lilly's £279m bet aims to boost UK life sciences sector
11.12.ASH 2024: J&J's Tecvayli shows promise in transplant-eligible NDMM patient
11.12.Dr Myles Greenberg becomes president and CEO of InCarda Therapeutics
10.12.ASH 2024: Regeneron's Ordspono faces challenges, but positive results signal hope
10.12.New Amsterdam stock jumps as LDL-C lowering drug scores again at Phase III
10.12.EMA validates Chiesi and Protalix's dose variation for Fabry disease
10.12.RSV prophylactic market to reach $6.2bn in 8MM by 2030
10.12.Santhera's DMD therapy Agamree approved for NHS use after new price deal
10.12.Seres' SER-155 gains breakthrough status for BSIs reduction
10.12.FDA to review GSK's Nucala for COPD
09.12.Daiichi Sankyo secures breakthrough designation for NSCLC treatment
09.12.Citryll gains Series B funds to develop NET-targeting antibody
09.12.Bringing Engineering to a New Level: ZETA's Integrated Approach
09.12.Reprieve for Chinese biotechs as BIOSECURE Act left out of key bill
09.12.Novo Holdings' acquisition of Catalent gains EC approval
09.12.Innovative Buffer Management Solutions: ZETA's Modular Buffer Inline Conditioning System
09.12.Priority FDA review given to AstraZeneca's Imfinzi sBLA for MIBC
06.12.FDA shares new draft guidance for accelerated approval
06.12.New study finds obesity costs US industry $347bn a year
06.12.Nature study finds obesity costs US industry $347bn a year
06.12.Cell and gene therapy companies must demonstrate strong value proposition for investment
06.12.Eli Lilly to invest $3bn in Wisconsin facility expansion